4Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease:description and critical assessment. Int J Gynecol Cancer,2001,11:73-77.
5Ngan S, Secki MJ. Gestational trophoblastic neoplasia management : an update. Curr Opin Onco1,2007 ,19 :486-491.
6Kira SJ, Bae SN, Kim JR, et al. Effects of multiagem chemotherapy and independent risk factors in the treatment of high-risk GTY:25 years experiences of KRI-TRD. Int J Gynaecol Obstet,1998,60 Suppl 1 :$85-96.
7Ma Y, Xiang Y, Wan XR, et al. The prognostic analysis of 123 postpartum choriocarcinoma cases. Int J Gynecol Cancer, 2008, 18 : 1097-1101.
8Tangir J, Zeltermart D, Ma W, et al. Reproductive function after conservative surge and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecal,2003,101:251-257.
9de La Motte Rouge T, Pautier P, Duvillard P, et al. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol,2008,19 : 1435-1441.
10Willemse PH, Aalders JG, Bouma J, et al. Chemotherapy- resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin. Obstet Gynecol, 1988, 71(3 Pt 2) :438-440.
